J. Gut

818 total citations
21 papers, 687 citations indexed

About

J. Gut is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, J. Gut has authored 21 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in J. Gut's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (3 papers) and Biomedical Text Mining and Ontologies (3 papers). J. Gut is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (3 papers) and Biomedical Text Mining and Ontologies (3 papers). J. Gut collaborates with scholars based in Switzerland, United States and Canada. J. Gut's co-authors include Pierre Dayer, Thomas Kronbach, Urs Meyer, Richard J. Cherry, Suguru Kawato, Christoph Richter, Kaspar H. Winterhalter, F Michot, Ulrich M. Zanger and U. Thomas Meier and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

J. Gut

21 papers receiving 658 citations

Peers

Countries citing papers authored by J. Gut

Since Specialization

Citations

This map shows the geographic impact of J. Gut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Gut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Gut more than expected).

Fields of papers citing papers by J. Gut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Gut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Gut. The network helps show where J. Gut may publish in the future.

Co-authorship network of co-authors of J. Gut

This figure shows the co-authorship network connecting the top 25 collaborators of J. Gut. A scholar is included among the top collaborators of J. Gut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Gut. J. Gut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ontology-based knowledge management of troglitazone-induced hepatotoxicity 2004 ·Drug Discovery Today ·(unknown), (unknown), R. Schindler, (unknown), André Stephan, (unknown), J. Gut	6
2	ADRIS – The Adverse Drug Reactions Information Scheme 2004 ·Clinical Neuropharmacology ·(unknown), (unknown), (unknown), R. Schindler, Oliver Horlacher, J. Gut	1
3	ADRIS ??? The Adverse Drug Reactions Information Scheme 2003 ·Pharmacogenetics ·(unknown), (unknown), (unknown), R. Schindler, Oliver Horlacher, J. Gut	5
4	Optical and acoustical interrogation of submicron contrast agents 2002 ·IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control ·(unknown), Paul A. Dayton, J. Gut, E.R. Wisner, Katherine W. Ferrara	25
5	Submicron contrast agents for the detection and localization of at risk lymph nodes 2002 ·(unknown), Paul A. Dayton, J. Gut, E.R. Wisner, Katherine W. Ferrara	1
6	Acoustic fragmentation of therapeutic contrast agents designed for localized drug delivery 2002 ·D May, John S. Allen, J. Gut, Katherine W. Ferrara	4
7	Molecular mimicry of CF3CO-lys by lipoic acid II: lipoic acid bearing proteins as autoantigens in halothane hepatitis 1994 ·Toxicology Letters ·Noel Frey, (unknown), J. Gut	1
8	Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione. 1991 ·Molecular Pharmacology ·Jörg Huwyler, Maria Bürgin, Tanja Zeugin, J. Gut	11
9	Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides. 1991 ·Molecular Pharmacology ·Urs Christen, Maria Bürgin, J. Gut	23
10	Single-step organic extraction of leukotrienes and related compounds and their simultaneous analysis by high-performance liquid chromatography 1990 ·Analytical Biochemistry ·Jörg Huwyler, J. Gut	12
11	Conversion of 5-hydroperoxyeicosatetraenoic acid into leukotriene B4 by rat hepatocytes: a novel cellular source for leukotriene B4. 1988 ·Molecular Pharmacology ·J. Gut, Dodi Goldman, James R. Trudell	12
12	Alcohol-Induced Bone Marrow Damage 1987 ·Acta Haematologica ·F Michot, J. Gut	33
13	Debrisoquine/sparteine-type polymorphism of drug oxidation. Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. 1986 ·Journal of Biological Chemistry ·J. Gut, (unknown), Pierre Dayer, Thomas Kronbach, Ulrich M. Zanger, Urs Meyer	99
14	The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation 1986 ·Xenobiotica ·Urs Meyer, J. Gut, Thomas Kronbach, (unknown), U. Thomas Meier, (unknown), Pierre Dayer	111
15	Steric configuration and polymorphic oxidation of lipophilic beta-adrenoceptor blocking agents: in vivo — in vitro correlations 1985 ·Biochemical Pharmacology ·Pierre Dayer, T. Leemann, J. Gut, Thomas Kronbach, A Küpfer, Robert J. Francis, Urs Meyer	27
16	Debrisoquine‐type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation 1984 ·FEBS Letters ·J. Gut, Robin B. Gasser, Pierre Dayer, Thomas Kronbach, (unknown), Urs Meyer	48
17	Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism) — Increased michaelis constant (km) and loss of stereoselectivity of bufuralol 1′-hydroxylation in poor metabolizers 1984 ·Biochemical and Biophysical Research Communications ·Pierre Dayer, Rodolfo Gasser, J. Gut, Thomas Kronbach, (unknown), Michel Eichelbaum, Urs Meyer	60
18	Rotation of cytochrome P-450. Complex formation of cytochrome P-450 with NADPH-cytochrome P-450 reductase in liposomes demonstrated by combining protein rotation with antibody-induced cross-linking. 1983 ·Journal of Biological Chemistry ·J. Gut, Christoph Richter, Richard J. Cherry, Kaspar H. Winterhalter, Suguru Kawato	57
19	Rotation of cytochrome P-450. I. Investigations of protein-protein interactions of cytochrome P-450 in phospholipid vesicles and liver microsomes. 1982 ·Journal of Biological Chemistry ·Suguru Kawato, J. Gut, Richard J. Cherry, Kaspar H. Winterhalter, Christoph Richter	83
20	Rotation of cytochrome P-450. II. Specific interactions of cytochrome P-450 with NADPH-cytochrome P-450 reductase in phospholipid vesicles. 1982 ·Journal of Biological Chemistry ·J. Gut, Christoph Richter, Richard J. Cherry, Kaspar H. Winterhalter, Suguru Kawato	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact